<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://www.w3.org/ns/prov#" xmlns:ns1="http://purl.org/dc/terms/" xmlns:ns2="http://purl.org/dc/elements/1.1/" xmlns:ns3="http://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:ns4="http://purl.obolibrary.org/obo/">
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00330_4_sequence/1">
    <sbol:displayId>sb8b00330_4_sequence</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:elements>cctatg</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00330_4_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00330_4_comp/1">
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00330_4_sequence/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00330"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_4_comp"/>
    <sbol:displayId>sb8b00330_4_comp</sbol:displayId>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00330_3_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb8b00330_3_sequence</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00330_3_sequence"/>
    <sbol:elements>agtatg</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00330_3_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00330"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_3_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb8b00330_3_comp</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00330_3_sequence/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00330_5_sequence/1">
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00330_5_sequence"/>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:elements>cacgcc</sbol:elements>
    <sbol:displayId>sb8b00330_5_sequence</sbol:displayId>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00330_2_comp/1">
    <sbol:displayId>sb8b00330_2_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_2_comp"/>
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00330_2_sequence/1"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00330"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00330_1_sequence/1">
    <sbol:displayId>sb8b00330_1_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
    <sbol:elements>ggaggc</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00330_1_sequence"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00330_5_comp/1">
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_5_comp"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00330_5_sequence/1"/>
    <sbol:displayId>sb8b00330_5_comp</sbol:displayId>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00330"/>
  </sbol:ComponentDefinition>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00330_6_comp/1">
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00330"/>
    <sbol:displayId>sb8b00330_6_comp</sbol:displayId>
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00330_6_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_6_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
  </sbol:ComponentDefinition>
  <sbol:Collection rdf:about="http://examples.org/Collection/sb8b00330/1">
    <ns1:description>Adeno-associated viruses (AAVs) are promising gene therapy vectors but may exhibit off-target delivery due to broad tissue tropism. We recently developed a synthetic protease-activatable AAV vector, named provector, that transduces cells preferentially in environments rich in matrix metalloproteinases (MMPs) which are elevated in a variety of diseases, including various cancers and heart diseases. The provector displays peptide locks made up of MMP recognition sites flanking an inactivating sequence (IS) composed of four aspartic acid residues (D4). When present, the IS prevents AAV from binding cell receptors and no transduction occurs (OFF state). High levels of MMPs cleave the recognition sequences and release the IS from the capsid surface, restoring cell receptor binding (ON state). The AAV9 provector prototype is not optimal as it displays baseline OFF transduction at 5&#8211;10% of that of the wild-type capsid, which can lead to off-target delivery. We hypothesized that changes to the IS may decrease OFF state transduction. We created a provector panel with IS of lengths 0 (D0) to 10 (D10) aspartic acid residues and characterized this panel in vitro. Notably, we find that the D10 provector has an OFF transduction of less than 1% of wild-type capsid and an ON/OFF transduction ratio of 27, the best outcome achieved for any provector thus far. In summary, our results enable us to define new design rules for the provector platform, specifically that (1) the IS is necessary for provector locking and (2) increasing the number of aspartic acid residues in this sequence improves locking.</ns1:description>
    <ns2:subject>synthetic
virology</ns2:subject>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00330_3_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_4_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_1_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_2_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00330_2_sequence/1"/>
    <ns1:dateCopyrighted>2019</ns1:dateCopyrighted>
    <ns1:rightsHolder>American Chemical Society</ns1:rightsHolder>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_3_comp/1"/>
    <ns2:publisher>American Chemical
Society</ns2:publisher>
    <ns2:type>research-article</ns2:type>
    <ns3:ownedBy rdf:resource="https://synbioks.org/user/myers"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00330_4_sequence/1"/>
    <ns1:abstract>Adeno-associated viruses (AAVs) are promising gene therapy vectors but may exhibit off-target delivery due to broad tissue tropism. We recently developed a synthetic protease-activatable AAV vector, named provector, that transduces cells preferentially in environments rich in matrix metalloproteinases (MMPs) which are elevated in a variety of diseases, including various cancers and heart diseases. The provector displays peptide locks made up of MMP recognition sites flanking an inactivating sequence (IS) composed of four aspartic acid residues (D4). When present, the IS prevents AAV from binding cell receptors and no transduction occurs (OFF state). High levels of MMPs cleave the recognition sequences and release the IS from the capsid surface, restoring cell receptor binding (ON state). The AAV9 provector prototype is not optimal as it displays baseline OFF transduction at 5&#8211;10% of that of the wild-type capsid, which can lead to off-target delivery. We hypothesized that changes to the IS may decrease OFF state transduction. We created a provector panel with IS of lengths 0 (D0) to 10 (D10) aspartic acid residues and characterized this panel in vitro. Notably, we find that the D10 provector has an OFF transduction of less than 1% of wild-type capsid and an ON/OFF transduction ratio of 27, the best outcome achieved for any provector thus far. In summary, our results enable us to define new design rules for the provector platform, specifically that (1) the IS is necessary for provector locking and (2) increasing the number of aspartic acid residues in this sequence improves locking.</ns1:abstract>
    <ns1:dateSubmitted>2018-08-02</ns1:dateSubmitted>
    <ns4:OBI_0001617>30614703</ns4:OBI_0001617>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00330_6_sequence/1"/>
    <ns2:creator>Tawana M. Robinson</ns2:creator>
    <sbol:version>1</sbol:version>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_6_comp/1"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00330_5_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_5_comp/1"/>
    <ns1:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb8b00330_1_sequence/1"/>
    <ns3:topLevel rdf:resource="https://synbioks.org/public/ACS/sb8b00330/1"/>
    <sbol:displayId>sb8b00330</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Collection/sb8b00330"/>
    <ns4:OBI_0002110>10.1021/acssynbio.8b00330</ns4:OBI_0002110>
    <ns1:references>Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., Spinale, F. G. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy Circulation 1998. 97:1708-1715.</ns1:references>
    <ns1:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
  </sbol:Collection>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00330_6_sequence/1">
    <sbol:elements>tcctct</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00330_6_sequence"/>
    <sbol:displayId>sb8b00330_6_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb8b00330_2_sequence/1">
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb8b00330_2_sequence"/>
    <sbol:version>1</sbol:version>
    <sbol:displayId>sb8b00330_2_sequence</sbol:displayId>
    <sbol:elements>agaggc</sbol:elements>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb8b00330_1_comp/1">
    <sbol:version>1</sbol:version>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb8b00330_1_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb8b00330_1_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.8b00330"/>
    <sbol:displayId>sb8b00330_1_comp</sbol:displayId>
  </sbol:ComponentDefinition>
</rdf:RDF>
